Case number 1:21-cv-01785
Astellas US LLC et al v. Hikma Pharmaceuticals USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 4, 2022 | 40 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME contentions, responses to RFP, meet and confers to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Jul 29, 2022 | 39 | SO ORDERED (2) Docket Text: SO ORDERED, re [38] STIPULATION TO EXTEND TIME Preliminary Disclosure of Asserted Claims and accompanying document production to August 1, 2022, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 7/29/2022. (kmd) |
| Jul 28, 2022 | 38 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Preliminary Disclosure of Asserted Claims and accompanying document production to August 1, 2022 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Jul 20, 2022 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of GE Healthcare Inc.'s First Set of Requests for Production of Documents to Plaintiffs (Nos. 1-4) filed by GE Healthcare Inc..(Brauerman, Stephen) |
| Jul 20, 2022 | 36 | SO ORDERED (2) Docket Text: SO ORDERED, re [35] STIPULATION TO EXTEND TIME contentions and disclosure of asserted claims to various, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 7/20/2022. (kmd) |
| Jul 19, 2022 | 35 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME contentions and disclosure of asserted claims to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Jun 30, 2022 | 34 | Answer to Counterclaim (9) Docket Text: ANSWER to [26] Answer to Complaint, Counterclaim of GE Healthcare, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Del Dotto, Kelly) |
| Jun 30, 2022 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant GE Healthcare Inc.'s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery and Defendant GE Healthcare Inc.'s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by GE Healthcare Inc..(Brauerman, Stephen) |
| Jun 30, 2022 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery and Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Del Dotto, Kelly) |
| Jun 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [31] STIPULATION TO EXTEND TIME to Extend Case Deadlines to Various Dates, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 6/22/2022. (kmd) |
| Jun 21, 2022 | 31 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Extend Case Deadlines to Various Dates - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Jun 14, 2022 | 30 | SO ORDERED (2) Docket Text: SO ORDERED, re [29] Stipulation of Dismissal as to Defendant Hikma Pharmaceuticals USA, Inc., filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Party Hikma Pharmaceuticals USA, Inc. terminated. Attorneys James Michael Lennon; Ellen Levish; Brandon J. Pakkebier; Jake M. Holdreith and Oren D. Langer terminated. Signed by Judge Colm F. Connolly on 6/14/2022. (kmd) |
| Jun 13, 2022 | 29 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Defendant Hikma Pharmaceuticals USA, Inc. by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jun 13, 2022 | 28 | SO ORDERED (2) Docket Text: SO ORDERED, re [25] STIPULATION TO EXTEND TIME ID of Asserted claims, Contentions to various, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 6/13/2022. (kmd) |
| Jun 10, 2022 | 27 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GE Healthcare USA Holding LLC for GE Healthcare Inc. filed by GE Healthcare Inc.. (Brauerman, Stephen) |
| Jun 10, 2022 | 26 | Answer to Complaint (29) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by GE Healthcare Inc..(Brauerman, Stephen) |
| Jun 10, 2022 | 25 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME ID of Asserted claims, Contentions to various - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Jun 7, 2022 | 24 | Scheduling Order (16) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 6/20/2022. Amended Pleadings due by 6/20/2022. Fact Discovery completed by 1/23/2023. Expert Discovery due by 8/15/2023. Proposed Pretrial Order due by 11/6/2023. A Final Pretrial Conference is set for 11/29/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 12/11/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/6/2022. (nmf) |
| Jun 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (8 in 1:22-cv-00523-CFC) MOTION to Consolidate Cases / GE Healthcare's Unopposed Motion to Consolidate filed by GE Healthcare Inc. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1785-CFC ONLY. Ordered by Judge Colm F. Connolly on 6/3/2022. Associated Cases: 1:22-cv-00523-CFC, 1:21-cv-01785-CFC(nmf) |
| Jun 2, 2022 | 23 | Proposed Order (16) Docket Text: PROPOSED ORDER Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| May 25, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before June 2, 2022, the parties shall resubmit their proposed scheduling order using the Court's Form Scheduling Order for Hatch-Waxman Patent Infringement cases. The parties shall include a Pretrial Conference date of November 29, 2023 at 3:00 p.m. and a Bench Trial date of December 11, 2023. Ordered by Judge Colm F. Connolly on 5/25/2022. (nmf) |
| May 9, 2022 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Corrected Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Del Dotto, Kelly) |
| May 9, 2022 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Rule 26(a)(1) Initial Disclosures; and (2) Defendant's Disclosures Pursuant to Paragraph 3 of the District of Delaware's Default Standard for Discovery Including Discovery of Electronically Stored Information (ESI) filed by Hikma Pharmaceuticals USA, Inc..(Lennon, James) |
| May 6, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery; and (2) Plaintiffs' Fed. R. Civ. P. 26(A)(1) Initial Disclosures filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Del Dotto, Kelly) |
| Apr 26, 2022 | 19 | Protective Order (27) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 4/26/2022. (kmd) |
| Apr 26, 2022 | 18 | Proposed Order (27) Docket Text: PROPOSED ORDER Protective Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Apr 26, 2022 | 17 | Proposed Order (17) Docket Text: PROPOSED ORDER Scheduling Order by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Apr 20, 2022 | 16 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Kelsey J. McElveen as co-counsel. Reason for request: leaving the firm April 22, 2022. (Lennon, James) |
| Mar 30, 2022 | 14 | Order (1) Docket Text: ORDER, On or before May 2, 2022, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 5/2/2022.) Signed by Judge Colm F. Connolly on 3/30/2022. (nmf) |
| Mar 30, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Jason Leonard, filed by Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 3/30/2022. (kmd) |
| Mar 30, 2022 | 15 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason Leonard - filed by Astellas Pharma US, Inc., Astellas US LLC. (Del Dotto, Kelly) |
| Mar 25, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ellen Levish for Hikma Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Oren D. Langer for Hikma Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith, Kelsey J. McElveen, Ellen K. Levish, and Oren D. Langer, filed by Hikma Pharmaceuticals USA, Inc. Ordered by Judge Colm F. Connolly on 3/24/2022. (kmd) |
| Mar 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jake M. Holdreith and Kelsey J. McElveen for Hikma Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 23, 2022 | 13 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by James Michael Lennon on behalf of Hikma Pharmaceuticals USA, Inc. (Lennon, James) |
| Mar 23, 2022 | 12 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith, Kelsey J. McElveen, Ellen K. Levish, and Oren D. Langer - filed by Hikma Pharmaceuticals USA, Inc.. (Lennon, James) |
| Mar 21, 2022 | 11 | Answer to Counterclaim (8) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim Answer to Defendant's Counterclaim by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Del Dotto, Kelly) |
| Mar 1, 2022 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals USA, Inc. filed by Hikma Pharmaceuticals USA, Inc.. (Lennon, James) |
| Feb 28, 2022 | 9 | Answer to Complaint (22) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Hikma Pharmaceuticals USA, Inc..(Lennon, James) |
| Jan 19, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 1/19/2022. (kmd) |
| Jan 18, 2022 | 8 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Jan 3, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.: For Hikma Pharmaceuticals USA, Inc. waiver sent on 12/29/2021, answer due 2/28/2022. (Del Dotto, Kelly) |
| Dec 29, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Dec 22, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
| Dec 22, 2021 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (nmg) |
| Dec 22, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc. and Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) |
| Dec 22, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183; US RE 47,301 E; US 8,524,883. (nmg) |
| Dec 22, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/13/2021. Date of Expiration of Patent: 2/2/2027.Thirty Month Stay Deadline: 5/13/2024. (nmg) |
| Dec 22, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Dec 22, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 22, 2021 | 1 | Exhibit D (18) |
| Dec 22, 2021 | 1 | Exhibit C (20) |
| Dec 22, 2021 | 1 | Exhibit B (22) |
| Dec 22, 2021 | 1 | Exhibit A (22) |
| Dec 22, 2021 | 1 | Main Document (13) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Hikma Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3768774.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(nmg) |
| Dec 22, 2021 | 1 | Complaint* (1) |
